Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity

被引：0
|
作者：
Kivrane, Agnija [1 ,2 ]
Ulanova, Viktorija [1 ,2 ]
Grinberga, Solveiga [3 ]
Sevostjanovs, Eduards [3 ]
Viksna, Anda [2 ,4 ]
Pole, Ilva [4 ]
Ozere, Iveta [2 ,4 ]
Bogdanova, Ineta [4 ]
Zolovs, Maksims [2 ,5 ]
Bandere, Dace [2 ]
Ranka, Renate [1 ,2 ]
机构：
[1] Latvian Biomed Res & Study Ctr, Riga, Latvia
[2] Riga Stradins Univ, Riga, Latvia
[3] Latvian Inst Organ Synth, Riga, Latvia
[4] Riga East Univ Hosp, Ctr TB & Lung Dis, Upeslejas, Latvia
[5] Daugavpils Univ, Daugavpils, Latvia
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2023年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
NORPM-P33
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [31] Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis
    Cho, Hyun-Jung
    Koh, Won-Jung
    Ryu, Yon-Ju
    Ki, Chang-Seok
    Nam, Myung-Hyun
    Kim, Jong-Won
    Lee, Soo-Youn
    TUBERCULOSIS, 2007, 87 (06) : 551 - 556
  • [32] Diabetes is Not Significantly Associated with Decreased First-Line Tuberculosis Drug Exposure
    Sturdy, Ann
    Romano, Federico
    Kipper, Karin
    Barrett, Jessica
    Whittington, Ashley
    Kon, Onn Min
    Oliver, Nick
    Pasca, Oscar Della
    Cooke, Graham
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152 : 43 - 44
  • [33] Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Review
    Ambreen, Khushboo
    Sharma, Rolee
    Singh, Kaleshwar P.
    Kumar, Sudhir
    INTERNATIONAL JOURNAL OF ADVANCED BIOTECHNOLOGY AND RESEARCH, 2014, 5 (03): : 423 - 437
  • [34] The management of anti-tuberculosis drug-induced hepatotoxicity
    Tahaoglu, K
    Ataç, G
    Sevim, T
    Törün, T
    Yazicioglu, Ö
    Horzum, G
    Gemci, I
    Öngel, A
    Kapakli, N
    Aksoy, E
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2001, 5 (01) : 65 - 69
  • [35] Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis
    Ben Mahmoud, L.
    Ghozzi, H.
    Kamoun, A.
    Hakim, A.
    Hachicha, H.
    Hammami, S.
    Sahnoun, Z.
    Zalila, N.
    Makni, H.
    Zeghal, K.
    PATHOLOGIE BIOLOGIE, 2012, 60 (05): : 324 - 330
  • [36] Antituberculosis drug-induced hepatotoxicity: a comparison between patients with and without human immunodeficiency virus seropositivity
    Magalhaes Coca, Natalia Saldanha
    Oliveira, Marcelo Silva
    Voieta, Izabela
    de Figueiredo Antunes, Carlos Mauricio
    Lambertucci, Jose Roberto
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2010, 43 (06) : 624 - 628
  • [37] FREQUENCY OF FIRST LINE ANTITUBERCULOSIS DRUG INDUCED HEPATITIS
    Ellahi, Ikram
    Ullah, Hafiz Inam
    Azhar, Zara
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (05): : 10016 - 10021
  • [38] Protective effect of N-acetyl cystein on antituberculosis drug-induced hepatotoxicity
    Baniasadi, Shadi
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (02) : 193 - 193
  • [39] Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis
    Singh, Abhijeet
    Prasad, Rajendra
    Balasubramanian, Viswesvaran
    Gupta, Nikhil
    Gupta, Pawan
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2015, 3 : S80 - S90
  • [40] Hepatotoxicity in patients taking rosiglitazone: was it drug-induced?
    Reactions Weekly, 2000, 788 (1) : 2 - 2
12345